Page 1 | Search Results | Blood Neoplasia | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Outcomes of immune checkpoint inhibitor rechallenge in relapsed/refractory Hodgkin lymphoma

Yoshito Nishimura, Yiqun Han, Nadia Toumeh, Guneet Janda, Yu Fujiwara, Urshila Durani, Grzegorz S. Nowakowski, Jonas Paludo, Stephen M. Ansell, Jithma P. Abeykoon

Blood Neoplasia (2025) 2 (3): 100134.

https://doi.org/10.1016/j.bneo.2025.100134

Published: 2025

Includes: Supplemental data

Journal Articles

Real-world outcomes with ibrutinib in relapsed or refractory mantle cell lymphoma: a Danish population-based study

Trine Trab, Iman Chanchiri, Ahmed Ludvigsen Al-Mashhadi, Emma Berggren Dall, Stine Rasch, Mette Johansen, Simon Husby, Mikkel Runason Simonsen, Michael Roost Clausen, Thomas Stauffer Larsen, Jacob Haaber Christensen, Robert Schou Pedersen, Mikael Frederiksen, Mats Jerkeman, Christian Bjørn Poulsen, Laura Mors Haunstrup, Peter Brown, Tarec Christoffer El-Galaly, Kirsten Grønbæk

Blood Neoplasia (2025) 2 (3): 100128.

https://doi.org/10.1016/j.bneo.2025.100128

Published: 2025

Includes: Supplemental data

Journal Articles

Prognostic impact of extranodal disease on PET/CT in follicular lymphoma: results from a validation study with ECOG 2408

Frederique St-Pierre, Stephen M. Broski, Zequn Sun, Masha Kocherginsky, Betsy LaPlant, Matthew J. Maurer, Andrew Quon, Lucia Baratto, Hatice Savas, Lale Kostakoglu, Jane N. Winter, Thomas E. Witzig, Brad Kahl, Andrew M. Evens, Leo I. Gordon

Blood Neoplasia (2025) 2 (3): 100113.

https://doi.org/10.1016/j.bneo.2025.100113

Published: 2025

Includes: Supplemental data

Journal Articles

Outcomes at a single institution with MTR induction and consolidation in the management of primary CNS lymphoma

Nikita K. Dave, Veronica Carvajal, Alex C. Watts, Jordan S. Carter, Michael Cook, Colin Thomas, Donald E. Tsai, Stephen J. Schuster, James N. Gerson, Stefan K. Barta, Jakub Svoboda, Elise A. Chong, Wei-Ting Hwang, Daniel J. Landsburg, Sunita D. Nasta

Blood Neoplasia (2025) 2 (3): 100102.

https://doi.org/10.1016/j.bneo.2025.100102

Published: 2025

Includes: Supplemental data

Journal Articles

Magnetic resonance spectroscopy–based detection of response to therapy targeting glutaminolysis in lymphoma

Kavindra Nath, Pradeep K. Gupta, Shengchun Wang, Alexander A. Shestov, Neil Sen, Shilpa Rao, Stepan Orlovskiy, Cosimo Lobello, David Rushmore, Fernando Arias-Mendoza, Johnvesly Basappa, David S. Nelson, Mariusz A. Wasik

Blood Neoplasia (2025) 2 (3): 100105.

https://doi.org/10.1016/j.bneo.2025.100105

Published: 2025

Includes: Supplemental data

Journal Articles

Reduced CD20 expression yields inferior survival in patients with B-cell lymphoma treated with CD20×CD3 antibodies

Emil Ramsø Kyvsgaard, Trine Lønbo Grantzau, Mia Dahl Sørensen, Michael Boe Møller, Lene Dissing Sjø, Morten Grauslund, Trine Trab, Linea Cecilie Melchior, Lærke Sloth Andersen, Caroline Riley, Carsten U. Niemann, Jacob Haaber, Thomas Stauffer Larsen, Michael Roost Clausen, Kirsten Grønbæk, Martin Hutchings, Simon Husby

Blood Neoplasia (2025) 2 (3): 100096.

https://doi.org/10.1016/j.bneo.2025.100096

Published: 2025

Includes: Supplemental data

Journal Articles

Real-world treatment patterns and clinical outcomes in patients with follicular lymphoma: a SEER-Medicare analysis

Dai Chihara, Shibing Yang, Savreet Bains Chawla, Guihua Zhang, Anthony Wang, Junhua Yu, Donald Arnette, Fernando Rivas Navarro, Julie Blaedel, Alex Mutebi

Blood Neoplasia (2025) 2 (2): 100080.

https://doi.org/10.1016/j.bneo.2025.100080

Published: 2025

Includes: Supplemental data

Journal Articles

Outcomes of follicular lymphoma with leukemic phase in the modern era: results from a large multicenter study

Blood Neoplasia (2025) 2 (1): 100063.

https://doi.org/10.1016/j.bneo.2024.100063

Published: 2025

Includes: Supplemental data

Journal Articles

Safety landscape of bispecific antibody therapy in non-Hodgkin lymphoma: a meta-analysis

Rodrigo Fonseca, Alex J. Liu, Blake T. Langlais, Diana Almader-Douglas, Holenarasipur R. Vikram, Talal Hilal

Blood Neoplasia (2025) 2 (1): 100061.

https://doi.org/10.1016/j.bneo.2024.100061

Published: 2025

Includes: Supplemental data

Journal Articles

Single-cell and spatial characterization of plasmablast-like lymphoma cells in primary central nervous system lymphoma

Hiroki Kobayashi, Ryota Chijimatsu, Yusuke Naoi, Yoshihiro Otani, Ryo Mizuta, Kentaro Fujii, Joji Ishida, Hiroyuki Murakami, Hideki Ujiie, Kazuhiro Ikeuchi, Tomohiro Urata, Keisuke Seike, Hideaki Fujiwara, Noboru Asada, Nobuharu Fujii, Ken-ichi Matsuoka, Yasuharu Sato, Yoshinobu Maeda, Daisuke Ennishi

Blood Neoplasia (2025) 2 (1): 100058.

https://doi.org/10.1016/j.bneo.2024.100058

Published: 2025

Includes: Supplemental data

Journal Articles

Pralatrexate injection combined with oral leucovorin for mucositis management in PTCL/CTCL treatment: a multicenter phase 2 trial

Swaminathan P. Iyer, Shaker Dakhil, Michi M. Shinohara, Jasmine Zain, Mark Acosta, Francine Foss

Blood Neoplasia (2024) 2 (1): 100055.

https://doi.org/10.1016/j.bneo.2024.100055

Published: 2024

Journal Articles

JAK1/2 inhibitor ruxolitinib for the treatment of systemic chronic active Epstein-Barr virus disease: a phase 2 study

Yu Uemura, Masahide Yamamoto, Masataka Ishimura, Hirokazu Kanegane, Akihisa Sawada, Akihiro Hirakawa, Ken-Ichi Imadome, Mayumi Yoshimori, Masashi Nagata, Kouhei Yamamoto, Norio Shimizu, Ryuji Koike, Ayako Arai

Blood Neoplasia (2024) 2 (1): 100053.

https://doi.org/10.1016/j.bneo.2024.100053

Published: 2024

Includes: Supplemental data

Journal Articles

Development and characterization of a low-affinity humanized CD19 chimeric antigen receptor for B-cell malignancies

Lawrence A. Stern, Vibhuti Vyas, Laura Lim, Christian Huynh, Ryan Urak, Ruby Espinosa, Zhiqiang Wang, Michalina Silva Thiel, John C. Williams, Stephen J. Forman, Christine E. Brown, Xiuli Wang

Blood Neoplasia (2024) 1 (4): 100048.

https://doi.org/10.1016/j.bneo.2024.100048

Published: 2024

Includes: Supplemental data

Journal Articles

COVID-19 vaccination in patients with classic and variant hairy cell leukemia

Robert J. Kreitman, Lacey James, Julie Feurtado, Holly Eager, Olena Sierra Ortiz, Mory Gould, Isaac Shpilman, Hong Zhou, Peter D. Burbelo, Jeffrey I. Cohen, Hao-Wei Wang, Constance M. Yuan, Evgeny Arons

Blood Neoplasia (2024) 1 (4): 100035.

https://doi.org/10.1016/j.bneo.2024.100035

Published: 2024

Journal Articles

CD5 expression in marginal zone lymphoma does not predict inferior outcome and has similarities to indolent lymphomas

Paola Ghione, Kurt S. Bantilan, Erel Joffe, M. Lia Palomba, Ariela Noy, Philip Caron, Paul Hamlin, Anita Kumar, Matthew Matasar, Colette Owens, Alison Moskowitz, Lorenzo Falchi, David Straus, Steven Horwitz, Gilles Salles, Ahmet Dogan, Andrew D. Zelenetz

Blood Neoplasia (2024) 1 (4): 100031.

https://doi.org/10.1016/j.bneo.2024.100031

Published: 2024

Journal Articles

CD38-CAR human NK cells in combination with ATRA enhance cytotoxicity against CD38-expressing hematologic malignancies

Ella Troy, Joseph Caporale, Yasemin Sezgin, Marcelo S. F. Pereira, Gregory Behbehani, Justin Lyberger, Dean A. Lee, Meisam Naeimi Kararoudi

Blood Neoplasia (2024) 1 (4): 100032.

https://doi.org/10.1016/j.bneo.2024.100032

Published: 2024

Includes: Supplemental data

Journal Articles

Clinical and pathological features of pediatric peripheral T-cell lymphoma after solid organ transplantation

Jinjun Cheng, Rachel Mariani, Jyotinder Nain Punia, Marimar de la Cruz Bonilla, Pichayut Nithagon, Metin Ozdemirli, Wen Shuai, Larry Wang, Oussama Abla, Shunyou Gong

Blood Neoplasia (2024) 1 (4): 100039.

https://doi.org/10.1016/j.bneo.2024.100039

Published: 2024

Includes: Supplemental data

Journal Articles

T-cell lymphoblastic lymphoma compared with T-cell acute lymphoblastic leukemia: similar subtypes and different fusions

Emma Kroeze, Michelle M. Kleisman, Rico Hagelaar, Reno S. Bladergroen, Lennart A. Kester, Marijn A. Scheijde-Vermeulen, Freerk van Dijk, Jules P. P. Meijerink, Roland P. Kuiper, Jan L. C. Loeffen

Blood Neoplasia (2024) 1 (3): 100029.

https://doi.org/10.1016/j.bneo.2024.100029

Published: 2024

Includes: Supplemental data

Journal Articles

Clinical outcomes of patients with newly diagnosed large B-cell lymphoma in a safety-net hospital system

Jun Y. Jiang, Chijioke Nze, Danielle Guffey, Rockbum Kim, Abiodun O. Oluyomi, Omar Rosales, Raka Bandyo, Courtney N. Miller-Chism, Mark M. Udden, Martha P. Mims, Hilary Ma, Gustavo A. Rivero, Akiva Diamond, Purnima S. Teegavarapu, Ang Li, Christopher R. Flowers

Blood Neoplasia (2024) 1 (3): 100020.

https://doi.org/10.1016/j.bneo.2024.100020

Published: 2024

Includes: Supplemental data

Journal Articles

Optimal number of cycles of bendamustine as initial chemoimmunotherapy for older patients with follicular lymphoma

Christopher S. Strouse, Vanessa E. Siebert, Bradley T. Loeffler, Bradley D. McDowell, Brian J. Smith, Brian K. Link

Blood Neoplasia (2024) 1 (3): 100019.

https://doi.org/10.1016/j.bneo.2024.100019

Published: 2024

Includes: Supplemental data

Update search

NARROW

Publications

Format

Subjects

Article Type

Date

Availability

Outcomes of immune checkpoint inhibitor rechallenge in relapsed/refractory Hodgkin lymphoma

Real-world outcomes with ibrutinib in relapsed or refractory mantle cell lymphoma: a Danish population-based study

Prognostic impact of extranodal disease on PET/CT in follicular lymphoma: results from a validation study with ECOG 2408

Outcomes at a single institution with MTR induction and consolidation in the management of primary CNS lymphoma

Magnetic resonance spectroscopy–based detection of response to therapy targeting glutaminolysis in lymphoma

Reduced CD20 expression yields inferior survival in patients with B-cell lymphoma treated with CD20×CD3 antibodies

Real-world treatment patterns and clinical outcomes in patients with follicular lymphoma: a SEER-Medicare analysis

Outcomes of follicular lymphoma with leukemic phase in the modern era: results from a large multicenter study

Safety landscape of bispecific antibody therapy in non-Hodgkin lymphoma: a meta-analysis

Single-cell and spatial characterization of plasmablast-like lymphoma cells in primary central nervous system lymphoma

Pralatrexate injection combined with oral leucovorin for mucositis management in PTCL/CTCL treatment: a multicenter phase 2 trial

JAK1/2 inhibitor ruxolitinib for the treatment of systemic chronic active Epstein-Barr virus disease: a phase 2 study

Development and characterization of a low-affinity humanized CD19 chimeric antigen receptor for B-cell malignancies

COVID-19 vaccination in patients with classic and variant hairy cell leukemia

CD5 expression in marginal zone lymphoma does not predict inferior outcome and has similarities to indolent lymphomas

CD38-CAR human NK cells in combination with ATRA enhance cytotoxicity against CD38-expressing hematologic malignancies

Clinical and pathological features of pediatric peripheral T-cell lymphoma after solid organ transplantation

T-cell lymphoblastic lymphoma compared with T-cell acute lymphoblastic leukemia: similar subtypes and different fusions

Clinical outcomes of patients with newly diagnosed large B-cell lymphoma in a safety-net hospital system

Optimal number of cycles of bendamustine as initial chemoimmunotherapy for older patients with follicular lymphoma

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only